{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:46:22Z","timestamp":1789069582408,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science and Technology Project of Health Commission of Jiangxi Province","award":["202410568"],"award-info":[{"award-number":["202410568"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s12072-024-10712-3","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T02:01:50Z","timestamp":1721440910000},"page":"1540-1554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The impact of artificial liver support system on intestinal microbiota and serum bile acid profiles in patients with acute-on-chronic liver failure: a prospective cohort study"],"prefix":"10.1007","volume":"18","author":[{"given":"Yuyu","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dakai","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaige","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanglan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4701-6002","authenticated-orcid":false,"given":"Molong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,20]]},"reference":[{"key":"10712_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, et al. Acute-on-chronic liver failure: consensus recommendations of the asian pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:353\u2013390","journal-title":"Hepatol Int"},{"key":"10712_CR2","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1111\/apt.14678","volume":"47","author":"K Ashby","year":"2018","unstructured":"Ashby K, Navarro Almario EE, Tong W, Borlak J, Mehta R, Chen M. Review article: therapeutic bile acids and the risks for hepatotoxicity. Aliment Pharmacol Ther. 2018;47:1623\u20131638","journal-title":"Aliment Pharmacol Ther"},{"key":"10712_CR3","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1053\/j.gastro.2016.08.057","volume":"151","author":"FJ Gonzalez","year":"2016","unstructured":"Gonzalez FJ, Jiang C, Patterson AD. An intestinal microbiota-farnesoid X receptor axis modulates metabolic disease. Gastroenterology. 2016;151:845\u2013859","journal-title":"Gastroenterology"},{"key":"10712_CR4","doi-asserted-by":"publisher","first-page":"G727","DOI":"10.1152\/ajpgi.00410.2001","volume":"283","author":"CR Webster","year":"2002","unstructured":"Webster CR, Usechak P, Anwer MS. cAMP inhibits bile acid-induced apoptosis by blocking caspase activation and cytochrome c release. Am J Physiol Gastrointest Liver Physiol. 2002;283:G727\u2013G738","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10712_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.taap.2015.01.015","volume":"283","author":"BL Woolbright","year":"2015","unstructured":"Woolbright BL, Dorko K, Antoine DJ, Clarke JI, Gholami P, Li F, et al. Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis. Toxicol Appl Pharmacol. 2015;283:168\u2013177","journal-title":"Toxicol Appl Pharmacol"},{"key":"10712_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.mam.2017.06.001","volume":"56","author":"M Li","year":"2017","unstructured":"Li M, Cai SY, Boyer JL. Mechanisms of bile acid mediated inflammation in the liver. Mol Aspects Med. 2017;56:45\u201353","journal-title":"Mol Aspects Med"},{"key":"10712_CR7","doi-asserted-by":"publisher","first-page":"1252035","DOI":"10.3389\/fped.2023.1252035","volume":"11","author":"P He","year":"2023","unstructured":"He P, Shen X, Guo S. Intestinal flora and linear growth in children. Front Pediatr. 2023;11:1252035","journal-title":"Front Pediatr"},{"key":"10712_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1152\/physrev.00049.2019","volume":"101","author":"A Perino","year":"2021","unstructured":"Perino A, Demagny H, Velazquez-Villegas L, Schoonjans K. Molecular physiology of bile acid signaling in health, disease, and aging. Physiol Rev. 2021;101:683\u2013731","journal-title":"Physiol Rev"},{"key":"10712_CR9","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","volume":"21","author":"SL Collins","year":"2023","unstructured":"Collins SL, Stine JG, Bisanz JE, Okafor CD, Patterson AD. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat Rev Microbiol. 2023;21:236\u2013247","journal-title":"Nat Rev Microbiol"},{"key":"10712_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ajpath.2010.11.026","volume":"178","author":"K Allen","year":"2011","unstructured":"Allen K, Jaeschke H, Copple BL. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am J Pathol. 2011;178:175\u2013186","journal-title":"Am J Pathol"},{"key":"10712_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13613-018-0453-z","volume":"8","author":"JJ Garc\u00eda Mart\u00ednez","year":"2018","unstructured":"Garc\u00eda Mart\u00ednez JJ, Bendjelid K. Artificial liver support systems: what is new over the last decade? Ann Intensive Care. 2018;8:109","journal-title":"Ann Intensive Care"},{"key":"10712_CR12","doi-asserted-by":"publisher","first-page":"E434","DOI":"10.1111\/aor.13710","volume":"44","author":"H Liu","year":"2020","unstructured":"Liu H, Zhang Q, Liu L, Cao Y, Ye Q, Liu F, et al. Effect of artificial liver support system on short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Artif Organs. 2020;44:E434\u2013E447","journal-title":"Artif Organs"},{"key":"10712_CR13","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/jgh.12932","volume":"30","author":"Y Chen","year":"2015","unstructured":"Chen Y, Guo J, Qian G, Fang D, Shi D, Guo L, et al. Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality. J Gastroenterol Hepatol. 2015;30:1429\u20131437","journal-title":"J Gastroenterol Hepatol"},{"key":"10712_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1900996","volume":"13","author":"K Wang","year":"2021","unstructured":"Wang K, Zhang Z, Mo ZS, Yang XH, Lin BL, Peng L, et al. Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure. Gut Microbes. 2021;13:1\u201315","journal-title":"Gut Microbes"},{"key":"10712_CR15","doi-asserted-by":"publisher","first-page":"2586052","DOI":"10.1155\/2018\/2586052","volume":"2018","author":"C Wu","year":"2018","unstructured":"Wu C, Zhu Y, Yu M. Serum metabonomics analysis of liver failure treated by nonbioartificial liver support systems. Can J Gastroenterol Hepatol. 2018;2018:2586052","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10712_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","volume":"60","author":"R Wiest","year":"2014","unstructured":"Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2014;60:197\u2013209","journal-title":"J Hepatol"},{"key":"10712_CR17","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jcmgh.2023.08.001","volume":"16","author":"B Shen","year":"2023","unstructured":"Shen B, Gu T, Shen Z, Zhou C, Guo Y, Wang J, et al. Escherichia coli promotes endothelial to mesenchymal transformation of liver sinusoidal endothelial cells and exacerbates nonalcoholic fatty liver disease via its flagellin. Cell Mol Gastroenterol Hepatol. 2023;16:857\u2013879","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10712_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.649060","volume":"11","author":"X Zhong","year":"2021","unstructured":"Zhong X, Cui P, Jiang J, Ning C, Liang B, Zhou J, et al. Streptococcus, the predominant bacterium to predict the severity of liver injury in alcoholic liver disease. Front Cell Infect Microbiol. 2021;11: 649060","journal-title":"Front Cell Infect Microbiol"},{"key":"10712_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/microorganisms7030078","volume":"7","author":"P Qin","year":"2019","unstructured":"Qin P, Zou Y, Dai Y, Luo G, Zhang X, Xiao L. Characterization a novel butyric acid-producing bacterium collinsella aerofaciens subsp Shenzhenensis Subsp Nov. Microorg. 2019;7:78","journal-title":"Microorg"},{"key":"10712_CR20","doi-asserted-by":"publisher","first-page":"2309683","DOI":"10.1080\/19490976.2024.2309683","volume":"16","author":"S Jin","year":"2024","unstructured":"Jin S, Chen P, Yang J, Li D, Liu X, Zhang Y, et al. Phocaeicola vulgatus alleviates diet-induced metabolic dysfunction-associated steatotic liver disease progression by downregulating histone acetylation level via 3-HPAA. Gut Microbes. 2024;16:2309683","journal-title":"Gut Microbes"},{"key":"10712_CR21","doi-asserted-by":"publisher","first-page":"1036196","DOI":"10.3389\/fimmu.2022.1036196","volume":"13","author":"L Liu","year":"2022","unstructured":"Liu L, Xu M, Lan R, Hu D, Li X, Qiao L, et al. Bacteroides vulgatus attenuates experimental mice colitis through modulating gut microbiota and immune responses. Front Immunol. 2022;13:1036196","journal-title":"Front Immunol"},{"key":"10712_CR22","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1161\/CIRCULATIONAHA.118.033714","volume":"138","author":"N Yoshida","year":"2018","unstructured":"Yoshida N, Emoto T, Yamashita T, Watanabe H, Hayashi T, Tabata T, et al. Bacteroides vulgatus and bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis. Circulation. 2018;138:2486\u20132498","journal-title":"Circulation"},{"key":"10712_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127648","volume":"282","author":"Z Chuandong","year":"2024","unstructured":"Chuandong Z, Hu J, Li J, Wu Y, Wu C, Lai G, et al. Distribution and roles of Ligilactobacillus murinus in hosts. Microbiol Res. 2024;282: 127648","journal-title":"Microbiol Res"},{"key":"10712_CR24","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/pathogens12091094","volume":"12","author":"Z Song","year":"2023","unstructured":"Song Z, Xie Q, Zhou Y, Song S, Gao Z, Lan Y, et al. Effect of artificial liver support systems on gut microbiota in patients with HBV-related acute-on-chronic liver failure. Pathogens. 2023;12:1094","journal-title":"Pathogens"},{"key":"10712_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107396","volume":"203","author":"J-F Goossens","year":"2019","unstructured":"Goossens J-F, Bailly C. Ursodeoxycholic acid and cancer: from chemoprevention to chemotherapy. Pharmacol Ther. 2019;203: 107396","journal-title":"Pharmacol Ther"},{"issue":"Suppl 1","key":"10712_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/liv.13306","volume":"37","author":"E de Vries","year":"2017","unstructured":"de Vries E, Beuers U. Management of cholestatic disease in 2017. Liver Int. 2017;37(Suppl 1):123\u2013129","journal-title":"Liver Int"},{"key":"10712_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbi.2021.09.021","volume":"99","author":"F Huang","year":"2022","unstructured":"Huang F, Pariante CM, Borsini A. From dried bear bile to molecular investigation: a systematic review of the effect of bile acids on cell apoptosis, oxidative stress and inflammation in the brain, across pre-clinical models of neurological, neurodegenerative and neuropsychiatric disorders. Brain Behav Immun. 2022;99:132\u2013146","journal-title":"Brain Behav Immun"},{"key":"10712_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40168-019-0628-3","volume":"7","author":"Z Song","year":"2019","unstructured":"Song Z, Cai Y, Lao X, Wang X, Lin X, Cui Y, et al. Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome. Microbiome. 2019;7:9","journal-title":"Microbiome"},{"key":"10712_CR29","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","volume":"582","author":"M Funabashi","year":"2020","unstructured":"Funabashi M, Grove TL, Wang M, Varma Y, McFadden ME, Brown LC, et al. A metabolic pathway for bile acid dehydroxylation by the gut microbiome. Nature. 2020;582:566\u2013570","journal-title":"Nature"},{"key":"10712_CR30","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/liv.13201","volume":"37","author":"T Horvatits","year":"2017","unstructured":"Horvatits T, Drolz A, Roedl K, Rutter K, Ferlitsch A, Fauler G, et al. Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis. Liver Int. 2017;37:224\u2013231","journal-title":"Liver Int"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10712-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-024-10712-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10712-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T15:08:26Z","timestamp":1728400106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-024-10712-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,20]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10712"],"URL":"https:\/\/doi.org\/10.1007\/s12072-024-10712-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4243220\/v1","asserted-by":"object"}]},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,20]]},"assertion":[{"value":"9 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yuyu Zeng, Dakai Gan, Kaige Zhang, Tao Long, Yan He, Rui Zhou, Shuanglan Liu and Molong Xiong declare that they have no conflict of interest. The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Informed consent was obtained from all patients for being included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}